Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis

The efficacy of cannabinoids in the treatment of multiple sclerosis is widely documented; however their use is limited by psychoactivity mainly ascribed to the activation of the cannabinoid receptor CB1. Emerging findings support as alternative strategy in the treatment of neurodegenerative disorder...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Malfitano, Anna Maria, Laezza, Chiara, D’Alessandro, Alba, Procaccini, Claudio, Saccomanni, Giuseppe, Tuccinardi, Tiziano, Manera, Clementina, Macchia, Marco, Matarese, Giuseppe, Gazzerro, Patrizia, Bifulco, Maurizio
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2013
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
https://ncbi.nlm.nih.gov/pubmed/23658734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0062511
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk